Your genes could guide your heart medication
NCT ID NCT06665919
Summary
This study tested whether using a patient's genetic information to choose a blood-thinning drug (like clopidogrel) leads to better outcomes after a heart stent procedure. Researchers compared a group that received treatment based on their genetics to a group that received the standard treatment. The goal was to see if this personalized approach could better prevent heart attacks, strokes, and death over a 12-month period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1st University Clinic of the Tbilisi State Medical University
Tbilisi, Georgia
-
Cardio Expert Ltd., Clinic Cardio
Tbilisi, Georgia
-
T. Oragvelidze Cardiology Center
Tbilisi, Georgia
-
Tbilisi Institute of Medicine
Tbilisi, Georgia
Conditions
Explore the condition pages connected to this study.